EPO Oppositions: Top Tips for Success

ARTICLE SUMMARY

A European Patent Office (EPO) Patent opposition is the legal process that allows anyone to challenge the validity of a EPO patent in all the territories where it is in force in a single action by filing an opposition against its grant on the basis of novelty, inventive step, industrial applicability, insufficiency and/or added matter.

authors
Related Services
Related Industries

A European Patent Office (EPO) Patent opposition is the legal process that allows anyone to challenge the validity of a EPO patent in all the territories where it is in force in a single action by filing an opposition against its grant on the basis of novelty, inventive step, industrial applicability, insufficiency and/or added matter.

The benefit of a successful opposition is simple. It could result in the complete revocation (cancellation) or limitation of a competitor patent in every state or territory covered by the patent, protecting your freedom to operate. It is therefore a cost-effective way to address infringement risk simultaneously in several markets. These benefits need to be balanced against the disadvantages of choosing to file an EPO opposition over national litigation and/or a UPC revocation action.

In this paper we share some of the experience and expertise the EPO oppositions and appeals specialists in our patent team have amassed from both perspectives: (i) effectively opposing a competitor’s patent and (ii) ensuring that defence against a potential opposition is as robust as possible.

Download White Paper

Discover how you can maximise the commercial and strategic value of your patent portfolio.

Thank you.
Your details have been submitted.
Download
Oops! Something went wrong while submitting the form.

Related News

Femtech is more than reproductive health: Where will the next wave of innovation come from?

Femtech is more than reproductive health: Where will the next wave of innovation come from?

The Autumn Budget 2026: Why UK innovators must focus on competitive advantage, not just innovation

The Autumn Budget 2026: Why UK innovators must focus on competitive advantage, not just innovation

Can AI inventions be patented?

Can AI inventions be patented?

Taking uterine fibroid research to Parliament

Taking uterine fibroid research to Parliament

Should startups be focusing on investor attractiveness rather than investor readiness?

Should startups be focusing on investor attractiveness rather than investor readiness?

ValueLicensing v Microsoft, GTA 6, and the death of the physical videogame

ValueLicensing v Microsoft, GTA 6, and the death of the physical videogame

Trade mark disputes: choosing your next move

Trade mark disputes: choosing your next move

Giulia Avellino on tackling inequalities in uterine fibroid care

Giulia Avellino on tackling inequalities in uterine fibroid care

See All News
No items found.